(Q57945468)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16781986%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16781986%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

0 references

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16781986%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Jeremy Chataway

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16781986%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Bernadette Porter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16781986%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Afsane Riazi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16781986%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Dominic Heaney

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16781986%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Hilary Watt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16781986%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Jeremy Hobart

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16781986%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16781986%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16781986%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16781986%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16781986%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

565-571

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16781986%20AND%20SRC:MED&resulttype=core&format=json

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970450-1

7 January 2021

Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970450-1

7 January 2021

Effect of relapses on development of residual deficit in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970450-1

7 January 2021

EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970450-1

7 January 2021

Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970450-1

7 January 2021

A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970450-1

7 January 2021

Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970450-1

7 January 2021

Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970450-1

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970450-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970450-1

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970450-1

7 January 2021

Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970450-1

7 January 2021

The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970450-1

7 January 2021

Costs and cost-minimisation analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970450-1

7 January 2021

Patients' experiences and satisfaction with health care: results of a questionnaire study of specific aspects of care

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970450-1

7 January 2021

10.1016/S1474-4422(06)70450-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16781986%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference